Rab27a and Rab27b are involved in stimulation-dependent RANKL release from secretory lysosomes in osteoblastic cells

Journal of Bone and Mineral Research

Volumn 26, Issue 4, 2011, Pages 689-703

  Kariya, Yoshiaki ^a,b   Honma, Masashi ^a   Hanamura, Akiko ^a   Aoki, Shigeki ^a   Ninomiya, Tadashi ^c   Nakamichi, Yuko ^c   Udagawa, Nobuyuki ^c   Suzuki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c MATSUMOTO DENTAL UNIVERSITY   (Japan)

Author keywords

JINX; RAB27A; RAB27B; RANKL; secretory lysosomes

Indexed keywords

CELL SURFACE PROTEIN; GUANOSINE TRIPHOSPHATASE; OSTEOCLAST DIFFERENTIATION FACTOR; RAB27A PROTEIN; RAB27B PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL MEMBRANE; CELL STIMULATION; CONJUGATION; CONTROLLED STUDY; GENE FUNCTION; GENE REPRESSION; IN VIVO STUDY; LYSOSOME; METAPHYSIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ACID PHOSPHATASE; ANIMALS; BONE AND BONES; BONE MARROW CELLS; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN TYPE I; GENE EXPRESSION; ISOENZYMES; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; LYSOSOMES; MACROPHAGES; MEMBRANE FUSION; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; OSTEOBLASTS; OSTEOCLASTS; PEPTIDES; PROTEIN BINDING; PROTEIN TRANSPORT; RAB GTP-BINDING PROTEINS; RANK LIGAND; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; SYNAPTOTAGMINS; TIBIA; VESICULAR TRANSPORT PROTEINS;

EID: 79953042881     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.268     Document Type: Article

References (54)

1. Hadjidakis DJ, Androulakis II,. Bone remodeling. Ann NY Acad Sci. 2006; 1092: 385-396. (Pubitemid 47092355)
2. Askmyr M, Sims NA, Martin TJ, Purton LE,. What is the true nature of the osteoblastic hematopoietic stem cell niche? Trends Endocrinol Metab. 2009; 20: 303-309.
3. Heymann D, Rousselle A,. Gp130 cytokine family and bone cells. Cytokine. 2000; 12: 1455-1468.
4. Collin-Osdoby P, Rothe L, Anderson F, Nelson M, Maloney W, Osdoby P,. Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem. 2001; 276: 20659-20672.
5. Katagiri T, Takahashi N,. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis. 2002; 8: 147-159. (Pubitemid 34535063)
6. Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999; 13: 2412-2424. (Pubitemid 29453612)
7. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999; 397: 315-323.
8. Naito A, Azuma S, Tanaka S, et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 1999; 4: 353-362. (Pubitemid 29359450)
9. Abu-Amer Y, Abbas S, Hirayama T,. TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis. J Cell Biochem. 2004; 93: 980-989. (Pubitemid 44264151)
10. Kanematsu M, Sato T, Takai H, Watanabe K, Ikeda K, Yamada Y,. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J Bone Miner Res. 2000; 15: 1321-1329. (Pubitemid 30413864)
11. Dai JC, He P, Chen X, Greenfield EM,. TNFalpha and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics. Bone. 2006; 38: 509-520.
12. Jimi E, Nakamura I, Amano H, et al. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology. 1996; 137: 2187-2190. (Pubitemid 26133995)
13. Mbalaviele G, Nishimura R, Myoi A, et al. Cadherin-6 mediates the heterotypic interactions between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiation. J Cell Biol. 1998; 141: 1467-1476. (Pubitemid 28289920)
14. Udagawa N, Takahashi N, Jimi E, et al. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone. 1999; 25: 517-523. (Pubitemid 29469457)
15. Kariya Y, Honma M, Aoki S, Chiba A, Suzuki H,. Vps33a mediates RANKL storage in secretory lysosomes in osteoblastic cells. J Bone Miner Res. 2009; 24: 1741-1752.
16. Aoki S, Honma M, Kariya Y, et al. Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis. J Bone Miner Res. 2010; 25: 1907-1921.
17. Zerial M, McBride H,. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol. 2001; 2: 107-117. (Pubitemid 33674039)
18. Hume AN, Ushakov DS, Tarafder AK, Ferenczi MA, Seabra MC,. Rab27a and MyoVa are the primary Mlph interactors regulating melanosome transport in melanocytes. J Cell Sci. 2007; 120 (Pt 17): 3111-3122. (Pubitemid 47517093)
19. Fukuda M, Imai A, Nashida T, Shimomura H,. Slp4-a/granuphilin-a interacts with syntaxin-2/3 in a Munc18-2-dependent manner. J Biol Chem. 2005; 280: 39175-39184. (Pubitemid 41713869)
20. Waselle L, Coppola T, Fukuda M, et al. Involvement of the Rab27 binding protein Slac2c/MyRIP in insulin exocytosis. Mol Biol Cell. 2003; 14: 4103-4113. (Pubitemid 37186312)
21. Shirakawa R, Higashi T, Tabuchi A, et al. Munc13-4 is a GTP-Rab27-binding protein regulating dense core granule secretion in platelets. J Biol Chem. 2004; 279: 10730-10737. (Pubitemid 38372686)
22. Tsuboi T, Fukuda M,. Rab3A and Rab27A cooperatively regulate the docking step of dense-core vesicle exocytosis in PC12 cells. J Cell Sci. 2006; 119 (Pt 11): 2196-2203. (Pubitemid 43960309)
23. Wu X, Rao K, Bowers MB, Copeland NG, Jenkins NA, Hammer JA 3rd., Rab27a enables myosin Va-dependent melanosome capture by recruiting the myosin to the organelle. J Cell Sci. 2001; 114 (Pt 6): 1091-1100. (Pubitemid 32288523)
24. Stinchcombe J, Barral D, Mules E, et al. Rab27a is required for regulated secretion in cytotoxic T lymphocytes. J Cell Biol. 2001; 152: 825-834.
25. Fukuda M, Kuroda TS, Mikoshiba K,. Slac2-a/melanophilin, the missing link between Rab27 and myosin Va: implications of a tripartite protein complex for melanosome transport. J Biol Chem. 2002; 277: 12432-12436. (Pubitemid 34952817)
26. Kuroda TS, Fukuda M,. Rab27A-binding protein Slp2-a is required for peripheral melanosome distribution and elongated cell shape in melanocytes. Nat Cell Biol. 2004; 6: 1195-1203. (Pubitemid 39625118)
27. Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003; 115: 461-473. (Pubitemid 37456808)
28. Holt O, Kanno E, Bossi G, et al. Slp1 and Slp2-a localize to the plasma membrane of CTL and contribute to secretion from the immunological synapse. Traffic. 2008; 9: 446-457. (Pubitemid 351351607)
29. Bossi G, Griffiths GM,. CTL secretory lysosomes: biogenesis and secretion of a harmful organelle. Semin Immunol. 2005; 17: 87-94. (Pubitemid 39575984)
30. Yamamoto K, Ishii E, Sako M, et al. Identification of novel MUNC13-4 mutations in familial haemophagocytic lymphohistiocytosis and functional analysis of MUNC13-4-deficient cytotoxic T lymphocytes. J Med Genet. 2004; 41: 763-767. (Pubitemid 39389293)
31. Pfeffer SR,. Two Rabs for exosome release. Nat Cell Biol. 12: 3-4.
32. Izumi T, Gomi H, Kasai K, Mizutani S, Torii S,. The roles of Rab27 and its effectors in the regulated secretory pathways. Cell Struct Funct. 2003; 28: 465-474. (Pubitemid 38256614)
33. Johnson JL, Brzezinska AA, Tolmachova T, et al. Rab27a and Rab27b regulate neutrophil azurophilic granule exocytosis and NADPH oxidase activity by independent mechanisms. Traffic. 2010; 11: 533-547.
34. Li X, Udagawa N, Takami M, Sato N, Kobayashi Y, Takahashi N,. p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology. 2003; 144: 4999-5005. (Pubitemid 37378415)
35. Sato N, Takahashi N, Suda K, et al. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. J Exp Med. 2004; 200: 601-611. (Pubitemid 39258309)
36. Ogata N, Chikazu D, Kubota N, et al. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest. 2000; 105: 935-943. (Pubitemid 30203066)
37. Eastell R, Mallinak N, Weiss S, et al. Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women. J Bone Miner Res. 2000; 15: 594-598. (Pubitemid 30134105)
38. Fukuda M,. Regulation of secretory vesicle traffic by Rab small GTPases. Cell Mol Life Sci. 2008; 65: 2801-2813.
39. Crozat K, Hoebe K, Ugolini S, et al. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J Exp Med. 2007; 204: 853-863. (Pubitemid 46631614)
40. Ma YL, Cain RL, Halladay DL, et al. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology. 2001; 142: 4047-4054. (Pubitemid 32802678)
41. Kitazawa R, Kitazawa S, Maeda S,. Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim Biophys Acta. 1999; 1445: 134-141. (Pubitemid 29193214)
42. Liu XH, Kirschenbaum A, Yao S, Levine AC,. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. Endocrinology. 2005; 146: 1991-1998. (Pubitemid 40396909)
43. Fukuda M,. Rab27 and its effectors in secretory granule exocytosis: a novel docking machinery composed of a Rab27. effector complex. Biochem Soc Trans. 2006; 34 (Pt 5): 691-695. (Pubitemid 44796400)
44. Blott EJ, Griffiths GM,. Secretory lysosomes. Nat Rev Mol Cell Biol. 2002; 3: 122-131.
45. Kondo H, Shirakawa R, Higashi T, et al. Constitutive GDP/GTP exchange and secretion-dependent GTP hydrolysis activity for Rab27 in platelets. J Biol Chem. 2006; 281: 28657-28665. (Pubitemid 44507008)
46. Meng Y, Graves L, Do TV, So J, Fishman DA,. Upregulation of FasL by LPA on ovarian cancer cell surface leads to apoptosis of activated lymphocytes. Gynecol Oncol. 2004; 95: 488-495. (Pubitemid 39592509)
47. Lettau M, Qian J, Linkermann A, et al. The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse. Proc Natl Acad Sci U S A. 2006; 103: 5911-5916.
48. Ivanov VN, Hei TK,. Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells. Exp Cell Res. 2006; 312: 1401-1417.
49. Trambas CM, Griffiths GM,. Delivering the kiss of death. Nat Immunol. 2003; 4: 399-403. (Pubitemid 36592428)
50. Chen D, Guo J, Miki T, Tachibana M, Gahl WA,. Molecular cloning and characterization of rab27a and rab27b, novel human rab proteins shared by melanocytes and platelets. Biochem Mol Med. 1997; 60: 27-37. (Pubitemid 27198147)
51. Barral D, Ramalho J, Anders R, et al. Functional redundancy of Rab27 proteins and the pathogenesis of Griscelli syndrome. J Clin Invest. 2002; 110: 247-257. (Pubitemid 34787362)
52. Tolmachova T, Abrink M, Futter C, Authi K, Seabra M,. Rab27b regulates number and secretion of platelet dense granules. Proc Natl Acad Sci U S A. 2007; 104: 5872-5877. (Pubitemid 47175626)
53. Tsuboi T, Fukuda M,. The Slp4-a linker domain controls exocytosis through interaction with Munc18-1. syntaxin-1a complex. Mol Biol Cell. 2006; 17: 2101-2112. (Pubitemid 44011727)
54. Torii S, Takeuchi T, Nagamatsu S, Izumi T,. Rab27 effector granuphilin promotes the plasma membrane targeting of insulin granules via interaction with syntaxin 1a. J Biol Chem. 2004; 279: 22532-22538. (Pubitemid 38679453)